Evidence map›Paper›PMID 42119036›Full record

ArticleDiseases of the esophagus : official journal of the International Society for Diseases of the Esophagus2026

Esophageal Cancer Patient Network: a scalable platform for integrating patient voices across the research lifecycle.

Talia Trottenberg, Mariam Hegazy, Sana Astany, Sam Sedighi, Sara Najmeh, Carmen Mueller, Jonathan Spicer, Jonathan Cools-Lartigue, Lorenzo Ferri, R Trafford Crump

Abstract read
In one paragraph

Article in Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Talia TrottenbergDivision of Thoracic and Upper Gastrointestinal Surgery, Department of Surgery, McGill University, Montreal, QC, Canada.
Mariam HegazyMcGill University Health Centre, Montreal, QC, Canada.
Sana AstanyDivision of Thoracic and Upper Gastrointestinal Surgery, Department of Surgery, McGill University, Montreal, QC, Canada.
Sam SedighiDivision of Thoracic and Upper Gastrointestinal Surgery, Department of Surgery, McGill University, Montreal, QC, Canada.
Sara NajmehDivision of Thoracic and Upper Gastrointestinal Surgery, Department of Surgery, McGill University, Montreal, QC, Canada.
Carmen MuellerDivision of Thoracic and Upper Gastrointestinal Surgery, Department of Surgery, McGill University, Montreal, QC, Canada.
Jonathan SpicerDivision of Thoracic and Upper Gastrointestinal Surgery, Department of Surgery, McGill University, Montreal, QC, Canada.
Jonathan Cools-LartigueDivision of Thoracic and Upper Gastrointestinal Surgery, Department of Surgery, McGill University, Montreal, QC, Canada.
Lorenzo FerriDivision of Thoracic and Upper Gastrointestinal Surgery, Department of Surgery, McGill University, Montreal, QC, Canada.
R Trafford CrumpDivision of Thoracic and Upper Gastrointestinal Surgery, Department of Surgery, McGill University, Montreal, QC, Canada.ORCID 0000-0001-6690-1926

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Esophageal cancer is associated with substantial symptom burden and long-term impacts on quality of life, yet research priorities have historically been shaped with limited direct input from patients and caregivers. Although patient engagement is increasingly recognized as essential for improving the relevance, feasibility, and accessibility of health research, existing national and international frameworks often provide limited guidance on how to operationalize engagement within specific disease contexts. This gap is particularly evidence in esophageal cancer, a relatively low-prevalence disease characterized by complex treatment pathways and heterogeneous patient experiences. To address this need, we established the Esophageal Cancer Patient Network (ECPN), a disease-specific patient engagement initiative designed as a reusable research tool rather than a single-project advisory group. This paper describes the conceptual foundation, governance structure, and implementation strategy of the ECPN. Central to the model is a publicly available Terms of Reference, a continuous engagement framework spanning the full research lifecycle, and clearly defined levels of patient involvement. The ECPN emphasized sustained engagement, enabling patients and caregivers to develop research-related expertise over time through training, mentorship, and repeated collaboration with clinicians and scientists. Designed to support multidisciplinary and international research, the ECPN facilitates collaboration across institutions and healthcare systems while remaining open to participation from patients, caregivers, and researchers beyond a single center. By providing practical infrastructure for sustained, transparent, and disease-specific patient engagement, the ECPN addresses a critical gap between high-level engagement principles and real-world implementation in esophageal cancer research.

Indexed as

Biomedical ResearchEsophageal NeoplasmsPatient ParticipationHumansQuality of LifeCommunity-Based Participatory ResearchEsophageal NeoplasmsPatient ParticipationResearch DesignStakeholder Participation

Identifiers

PMID42119036
PMCPMC13166880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.